NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most fatal cancers, and its molecular basis needs to be delineated to identify biomarkers for its potential treatment. The purpose of this study was to identify a novel gene, nucleosome assembly proteins 1-like 1 protein (NAP1L1), associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Yong, Kan, Anna, Li, Qi-Jiong, He, Min-Ke, Chen, Hai-Long, Shi, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729091/
https://www.ncbi.nlm.nih.gov/pubmed/31516385
http://dx.doi.org/10.1186/s12935-019-0949-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729091/
https://www.ncbi.nlm.nih.gov/pubmed/31516385
http://dx.doi.org/10.1186/s12935-019-0949-0

Ejemplares similares